Wouter M Sluis Selected Research

Antiemetics

1/2024

Prevention of infections and fever to improve outcome in older patients with acute stroke (PRECIOUS): a randomised, open, phase III, multifactorial, clinical trial with blinded outcome assessment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wouter M Sluis Research Topics

Disease

4	Stroke (Strokes) 01/2024 - 01/2021
2	Ischemic Stroke 01/2024 - 01/2023
1	Hyperglycemia 01/2023
1	Infections 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2022

Drug/Important Bio-Agent (IBA)

2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2024 - 01/2022
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 01/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2024
1	AntiemeticsIBA 01/2024
1	Metoclopramide (Reglan)FDA LinkGeneric 01/2024
1	AntipyreticsIBA 01/2024
1	Tranexamic Acid (AMCA)FDA Link 01/2022
1	AnticoagulantsIBA 01/2021

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2023
1	Thrombectomy 01/2023
1	Therapeutics 01/2021